FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Simone, R., Balendra, R., Moens, T.G., Preza, E., Wilson, K.M., Heslegrave, A., Woodling, N.S., Niccoli, T., Gilbert-Jaramillo, J., Abdelkarim, S., Clayton, E.L., Clarke, M., Konrad, M.T., Nicoll, A.J., Mitchell, J.S., Calvo, A., Chio, A., Houlden, H., Polke, J.M., Ismail, M.A., Stephens, C.E., Vo, T., Farahat, A.A., Wilson, W.D., Boykin, D.W., Zetterberg, H., Partridge, L., Wray, S., Parkinson, G., Neidle, S., Patani, R., Fratta, P., Isaacs, A.M. (2018). G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.  EMBO Mol. Med. 10(1): 22--31.
FlyBase ID
FBrf0237715
Publication Type
Research paper
Abstract
Intronic GGGGCC repeat expansions in C9orf72 are the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), which are characterised by degeneration of cortical and motor neurons, respectively. Repeat expansions have been proposed to cause disease by both the repeat RNA forming foci that sequester RNA-binding proteins and through toxic dipeptide repeat proteins generated by repeat-associated non-ATG translation. GGGGCC repeat RNA folds into a G-quadruplex secondary structure, and we investigated whether targeting this structure is a potential therapeutic strategy. We performed a screen that identified three structurally related small molecules that specifically stabilise GGGGCC repeat G-quadruplex RNA. We investigated their effect in C9orf72 patient iPSC-derived motor and cortical neurons and show that they significantly reduce RNA foci burden and the levels of dipeptide repeat proteins. Furthermore, they also reduce dipeptide repeat proteins and improve survival in vivo, in GGGGCC repeat-expressing Drosophila. Therefore, small molecules that target GGGGCC repeat G-quadruplexes can ameliorate the two key pathologies associated with C9orf72 FTD/ALS These data provide proof of principle that targeting GGGGCC repeat G-quadruplexes has therapeutic potential.
PubMed ID
PubMed Central ID
PMC5760849 (PMC) (EuropePMC)
Related Publication(s)
Note

Targeting RNA G-quadruplexes as new treatment strategy for C9orf72 ALS/FTD.
Schludi and Edbauer, 2018, EMBO Mol. Med. 10(1): 4--6 [FBrf0264965]

Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    EMBO Mol. Med.
    Title
    EMBO molecular medicine
    ISBN/ISSN
    1757-4676 1757-4684
    Data From Reference
    Genes (1)
    Human Disease Models (1)